Clinical Chemistry
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Clinical Chemistry 52: 2087-2094, 2006. First published September 21, 2006; 10.1373/clinchem.2006.068783
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
clinchem.2006.068783v1
52/11/2087    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (1)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Benn, P. A.
Right arrow Articles by Wright, D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Benn, P. A.
Right arrow Articles by Wright, D.
Related Collections
Right arrow General Clinical Chemistry
Right arrow Informatics and Statistics
Right arrow Proteomics and Protein Markers
Right arrow Endocrinology and Metabolism
(Clinical Chemistry. 2006;52:2087-2094.)
© 2006 American Association for Clinical Chemistry, Inc.

General Clinical Chemistry

Reproducibility of Risk Figures in 2nd-Trimester Maternal Serum Screening for Down Syndrome: Comparison of 2 Laboratories

Peter A. Benn1,a, Gregory S. Makowski2,1, James F.X. Egan3 and Dave Wright4

1 Division of Human Genetics, Department of Genetics and Developmental Biology, 2 Department of Laboratory Medicine, and 3 Department of Obstetrics and Gynecology, University of Connecticut Health Center, Farmington, CT.
4 Department of Mathematics and Statistics, University of Plymouth, Plymouth, United Kingdom.

aAddress correspondence to this author at: University of Connecticut Health Center, Division of Human Genetics, Department of Genetics and Developmental Biology, 263 Farmington Ave., Farmington, CT 06030-6140. Fax 860-679-3616; e-mail Benn{at}nso1.uchc.edu.

Background: Analytical error affects 2nd-trimester maternal serum screening for Down syndrome risk estimation. We analyzed the between-laboratory reproducibility of risk estimates from 2 laboratories.

Methods: Laboratory 1 used Bayer ACS180 immunoassays for {alpha}-fetoprotein (AFP) and human chorionic gonadotropin (hCG), Diagnostic Systems Laboratories (DSL) RIA for unconjugated estriol (uE3), and DSL enzyme immunoassay for inhibin-A (INH-A). Laboratory 2 used Beckman immunoassays for AFP, hCG, and uE3, and DSL enzyme immunoassay for INH-A. Analyte medians were separately established for each laboratory. We used the same computational algorithm for all risk calculations, and we used Monte Carlo methods for computer modeling.

Results: For 462 samples tested, risk figures from the 2 laboratories differed >2-fold for 44.7%, >5-fold for 7.1%, and >10-fold for 1.7%. Between-laboratory differences in analytes were greatest for uE3 and INH-A. The screen-positive rates were 9.3% for laboratory 1 and 11.5% for laboratory 2, with a significant difference in the patients identified as screen-positive vs screen-negative (McNemar test, P <0.001). Computer modeling confirmed the large between-laboratory risk differences.

Conclusion: Differences in performance of assays and laboratory procedures can have a large effect on patient-specific risks. Screening laboratories should minimize test imprecision and ensure that each assay performs in a manner similar to that assumed in the risk computational algorithm.




The following articles in journals at HighWire Press have cited this article:


Home page
 Hum Reprod UpdateHome page
M.A. Durand, J. Boivin, and G. Elwyn
A review of decision support technologies for amniocentesis
Hum. Reprod. Update, November 1, 2008; 14(6): 659 - 668.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2006 by the American Association for Clinical Chemistry.